NCT05015361View on ClinicalTrials.gov

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

June 18, 2021

Study Completion Date

July 4, 2021

Conditions
Local Anesthesia Assisted Sedation
Interventions
DRUG

Remimazolam Tosilate

Treatment group A: Remimazolam Tosilate; high dose Treatment group B: Remimazolam Tosilate; low dose

DRUG

Propofol Injection.

Treatment group C: Propofol Injection.

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY